Breath test with small intestinal bacterial overgrowth
- Conditions
- small intestinal bacterial overgrowth
- Registration Number
- JPRN-jRCTs061230012
- Lead Sponsor
- Isomoto Hajime
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
(1)18 or above years old male or female
(2)Patients with symptoms such as abdominal distention, abdominal pain, flatulence, burping, abdominal discomfort, chronic diarrhea/constipation lasting more than 3 months
(3) Patients who are not infected with H. Pylori
(4)Patients whose abdominal symptoms have not been identified by previous CT scan or upper gastrointestinal endoscopy.
(5) Patients who are scheduled to undergo upper gastrointestinal endoscopy as a routine medical examination
(1)Patients who have galactosemia
(2)Patients who have taken antibiotics within 1 month
(3)Patientswho have taken an intestinal antiflatulent, intestinal peristaltic, or PPI within 1 week
(4)Patients requiring the use of glucagon for endoscopy
(5)Diabetics with poorly controlled blood glucose (Hyperglycemia is expected after taking 10 g of lactulose)
(6)Patients taking oral alpha-glucosidase inhibitors
(7)Patients who have received other research or investigational drugs within 3 months prior to the start of treatment
(8)Pregnant women or patients who may be pregnant
(9)Patients who are breast-feeding
(10)Patients with organic disease (tumor, acute ulcerative lesion, severe stenosis or obstruction, etc.)
(11)Patients deemed inappropriate by the principal investigator and research staff
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method